Fortune 500 medical devices manufacturer was experiencing losses in market share and difficulties in penetrating key non-acute markets.
UAG conducted extensive market analysis and specific non-acute data gathering including key voice of the customer interviews.
Armed with this data, UAG then optimized resource deployment by increasing coverage in high-potential areas and employing data-driven market segmentation and customer targeting strategies under zero and positive investment scenarios.
Client realized that sales force structure and resource allocation was fundamentally flawed, expending resources against non-priority market segments.
Having reallocated resources and adjusting product suite/pricing, client was able to generate key inroads into otherwise inaccessible, large IDNs, increasing both market share and penetration.